Latest filing published 10 Jun 2026 for 通策医疗, €64k. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
王毅 (board member) discloses dealings in 2 companies, chiefly 通策医疗 and 扬杰科技. The record holds 3 filings, for trades running from 19 November 2021 to 10 June 2026.
No open-market sale appears; the market trades are 3 purchases worth €191k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 2 purchases and no sales.
In size, the median ticket on the buying side is €64k. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -13.5%. These figures describe past trades and do not predict future prices.
Most recently, on 10 June 2026, the filings show an open-market purchase worth €64k in 通策医疗. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations